Resultados de la búsqueda 131-140 de 2999 para anti-TNF drugs

  1. Programa de terapia de células T con receptores de antígeno quimérico - Ensayos clínicos

    ... anti-neutrophil cytoplasmic antibody (ANCA) ... CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... The purpose of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... therapy. Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer ...

  3. Terapia de medicina nuclear - Ensayos clínicos

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  4. Arteritis de Takayasu - Diagnóstico y tratamiento - Mayo Clinic

    Los ejemplos para tratar las anomalías biológicas son etanercept (Enbrel), infliximab (Remicade) y tocilizumab (Actemra). El efecto secundario más frecuente ...

  5. Schwannomatosis - Diagnósticos y tratamientos - Mayo Clinic

    Pain medicines. Managing pain is an important part of treatment for SMARCB1- and LZTR1-related schwannomatosis. Your healthcare professional might recommend:.

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  8. Terapia hormonal para el cáncer de mama - Mayo Clinic

    Hormone therapy for breast cancer. National Cancer Institute. https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet. Accessed Jan. 9, 2023.

  9. Neurobiology of Neurodegenerative Diseases Wilfried O Rossoll.

  10. Radiología - Ensayos clínicos - Mayo Clinic

    ... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...